Love the thread... but serious question to throw out there.
How can we tell how much of the key milestone to spend $6 million on CF33 Research and Development by 8th July 2021 has been done.
Other milestone by this date is Dosing first patient in a Phase 1 trial, but this depends entirely on upon FDA IND approval.
Can see that received FDA guidance in August 2020 from pre IND meeting, but nothing further such as other pre clinical or toxicity testing has been mentioned that is underway.
If total R & D for 2020 year was $7million would think more than 3/4 world be from current ongoing Bvax and HerVax trials and bit towards the PD1-VAX that started end of 2020.
What happens if this milestone is missed?
The Pissing & Moaning Thread, page-8
-
- There are more pages in this discussion • 216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.8¢ |
Change
0.006(9.68%) |
Mkt cap ! $499.7M | |||
| Open | High | Low | Value | Volume |
| 7.3¢ | 8.1¢ | 6.7¢ | $14.56M | 194.2M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 605784 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.8¢ | 159880 | 2 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |